List of compounds used under study, their classification, and their binding energy.
Rank | Compound | Molecule ID | Classification | Binding energy (kcal mol−1) |
---|---|---|---|---|
1a | Ribavirin 5′-triphosphate | PubChem CID: 122108 | Miscellaneous nucleoside | −7.41 |
2a | Favipiravir triphosphate (RTP) | PubChem CID: 5271809 | Miscellaneous nucleoside | −7.36 |
3 | 2′-c-Methylcytidine triphosphate | PubChem CID: 15940324 | Pyrimidine nucleoside | −7.19 |
4b | Pimodivir | CAS #: 1629869-44-8 | Non-nucleoside inhibitors | −7.18 |
5 | Galidesivir triphosphate | PubChem CID: 146047139 | Purine nucleoside | −7.12 |
6b | Dihydropyrazolopyridinone analogue 8d | PubChem CID: 23646185 | Non-nucleoside inhibitors | −6.98 |
7 | Dihydropyrazolopyridinone analogue 8b | PubChem CID: 23646183 | Non-nucleoside inhibitors | −6.93 |
8 | Remdesivir triphosphate | PubChem CID: 56832906 | Purine nucleoside | −6.88 |
9 | Favipiravir | CAS #: 259793-96-9 | Miscellaneous nucleoside | −6.87 |
10 | Dihydropyrazolopyridinone analogue 8a | PubChem CID: 23646182 | Non-nucleoside inhibitors | −6.76 |
11 | N4-Hydroxycytidine 5′-triphosphate | PubChem CID: 147591 | Pyrimidine nucleoside | −6.54 |
12 | Grazoprevir | PubChem CID: 44603531 | Non-nucleoside inhibitors | −6.34 |
13 | Radalbuvir | CAS #: 1314795-11-3 | Non-nucleoside inhibitors | −6.28 |
14 | Benzimidazole analogue, 7g | PubChem CID: 44143448 | Non-nucleoside inhibitors | −6.24 |
15 | Setrobuvir | CAS #: 1071517-39-9 | Non-nucleoside inhibitors | −6.23 |
16 | Deleobuvir | CAS #: 1221574-24-8 | Non-nucleoside inhibitors | −6.22 |
17 | PSI-6130 | CAS #: 817204-33-4 | Pyrimidine nucleoside | −6.21 |
18 | AL-335 | CAS #: 1613589-09-5 | Pyrimidine nucleoside | −6.21 |
19 | Ribavirin | CAS #: 36791-04-5 | Miscellaneous nucleoside | −6.21 |
20 | ALS-8112 | CAS #: 798009-58-2 | Pyrimidine nucleoside | −6.11 |
21 | PSI-7851 | CAS #: 1064684-44-1 | Pyrimidine nucleoside | −6.1 |
22 | VCH-759 | CAS #: 713139-25-4 | Nonnucleoside inhibitors | −5.92 |
23 | Nuc | CAS #: 1191237-69-0 | Purine nucleoside | −5.9 |
24 | PSI-7976 | CAS #: 1190308-01-0 | Pyrimidine nucleoside | −5.82 |
25 | VX-135 | CAS #: 798007-79-1 | Pyrimidine nucleoside | −5.78 |
26 | 2′-c-Methylcytidine | CAS #: 20724-73-6 | Pyrimidine nucleoside | −5.76 |
27 | Sofosbuvir | CAS #: 1190307-88-0 | Pyrimidine nucleoside | −5.76 |
28 | Lumicitabine | CAS #: 1445385-02-3 | Pyrimidine nucleoside | −5.73 |
29 | Benzimidazole analogue, 7e | PubChem CID: 44143432 | Non-nucleoside inhibitors | −5.68 |
30 | JNJ-54257099 | CAS #: 1255860-33-3 | Pyrimidine nucleoside | −5.67 |
31 | Dasabuvir | CAS #: 1132935-63-7 | Non-nucleoside inhibitors | −5.67 |
32 | MK-3281 | CAS #: 886043-45-4 | Non-nucleoside inhibitors | −5.66 |
33 | Filibuvir | CAS #: 877130-28-4 | Non-nucleoside inhibitors | −5.66 |
34 | JTK-109 | CAS #: 480462-62-2 | Non-nucleoside inhibitors | −5.65 |
35 | PSI-7672 | CAS #: 1015255-46-5 | Pyrimidine nucleoside | −5.63 |
36 | Biphenyl diamine analogue, 20 | PubChem CID: 25218554 | Non-nucleoside inhibitors | −5.62 |
37 | Aminophenol analogue, 6 | PubChem CID: 25158538 | Non-nucleoside inhibitors | −5.59 |
38 | EIDD-2801 | CAS #: 2349386-89-4 | Pyrimidine nucleoside | −5.52 |
39 | PSI-6206 | CAS #: 1064684-44-1 | Pyrimidine nucleoside | −5.45 |
40 | NHC | CAS #: 3258-02-4 | Pyrimidine nucleoside | −5.44 |
41 | Mericitabine | CAS #: 940908-79-2 | Pyrimidine nucleoside | −5.43 |
42 | INX-189 | CAS #: 1234490-83-5 | Purine nucleoside | −5.43 |
43 | Valopicitabine | CAS #: 640281-90-9 | Pyrimidine nucleoside | −5.42 |
44 | ACH-3422 | CAS #: 798779-31-4 | Pyrimidine nucleoside | −5.41 |
45 | VCH-916 | CAS #: 1200133-34-1 | Non-nucleoside inhibitors | −5.28 |
46 | IDX-375 | CAS #: 1256735-81-5 | Non-nucleoside inhibitors | −5.28 |
47 | Benzimidazole analogue, 5a | PubChem CID: 44143438 | Non-nucleoside inhibitors | −5.28 |
48 | Benzimidazole analogue, 7m | PubChem CID: 44143453 | Non-nucleoside inhibitors | −5.2 |
49 | Aminothiazole analogue, 32 | PubChem CID: 16068523 | Non-nucleoside inhibitors | −5.2 |
50 | Benzimidazole analogue, 7l | PubChem CID: 44143452 | Non-nucleoside inhibitors | −5.17 |
51 | BI 2536 analogue, 1b | PubChem CID: 11511524 | Non-nucleoside inhibitors | −5.17 |
52 | IDX-184 | CAS #: 1036915-08-8 | Purine nucleoside | −5.16 |
53 | HCV-371 | CAS #: 675184-27-7 | Non-nucleoside inhibitors | −5.14 |
54 | Tegobuvir | CAS #: 1000787-75-6 | Non-nucleoside inhibitors | −5.14 |
55 | Benzimidazole analogue, 5c | PubChem CID: 44143440 | Non-nucleoside inhibitors | −5.14 |
56 | Lomibuvir | CAS #: 1026785-55-6 | Non-nucleoside inhibitors | −5.11 |
57 | Nesbuvir | CAS #: 1132935-63-7 | Non-nucleoside inhibitors | −5.11 |
58 | Benzimidazole analogue, 5b | PubChem CID: 44143439 | Non-nucleoside inhibitors | −5.11 |
59 | 4′-Azido-2′-deoxy-2′-C-methylcytidine | CAS #: 1019639-20-3 | Pyrimidine nucleoside | −4.88 |
60 | TMC-649128 | CAS #: 1019639-33-8 | Pyrimidine nucleoside | −4.76 |
61 | Galidesivir | CAS #: 249503-25-1 | Purine nucleoside | −4.69 |
62 | Remdesivir | CAS #: 1809249-37-3 | Purine nucleoside | −4.64 |
63 | Benzimidazole analogue, 7h | PubChem CID: 44143433 | Non-nucleoside inhibitors | −4.35 |
64 | GSK-625433 | CAS #: 885264-71-1 | Non-nucleoside inhibitors | −4.34 |
65 | Benzimidazole analogue, 7n | PubChem CID: 44143454 | Non-nucleoside inhibitors | −4.34 |
66 | Beclabuvir | CAS #: 958002-33-0 | Non-nucleoside inhibitors | −4.33 |
67 | ABT-072 | CAS #: 1132936-00-5 | Non-nucleoside inhibitors | −4.33 |
68 | AT-527 | CAS #: 2241337-84-6 | Purine nucleoside | −4.32 |
69 | BILB-1941 | CAS #: 494856-61-0 | Non-nucleoside inhibitors | −4.32 |
70 | Benzimidazole analogue, 7a | PubChem CID: 44143444 | Non-nucleoside inhibitors | −4.28 |
71 | Kinome_3461 | PubChem CID: 25263111 | Non-nucleoside inhibitors | −4.28 |
72 | Aminothiazole analogue, 21 | PubChem CID: 16068527 | Non-nucleoside inhibitors | −4.28 |
The top two chosen nucleoside/nucleotide analogues as inhibitors for further studies.
The top two chosen nonnucleoside/non-nucleotide analogues as inhibitors for further studies.